Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
Reviewers:
(1) Ali Osman Gürol, Istanbul University, Turkey.
(2) Krishnaswamy Sampathkumar, Meenakshi Mission Hospital and Research Centre, India.
Additional Reviewers:
(1) Oguz Karahan, Medical School of Alaaddin Keykubat University, Turkey.
(2) Walaa Fikry Elbossaty, Damietta University, Egypt.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Ali Osman Gürol, Turkey) | File 1 | File 2
Stage 2 | Peer review report_2 (Krishnaswamy Sampathkumar, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA